 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
6-7-2023
Insider Buy |
William H. Fenstermaker
Director |
$11.62
CAGR »
|
$116,196.50
10,000 shares |
5-19-2023
Insider Buy |
Vicki R. Palmer
Director |
$11.02
CAGR »
|
$22,041.40
2,000 shares |
5-12-2023
Insider Buy |
William H. Fenstermaker
Director |
$9.56
CAGR »
|
$28,189.50
2,950 shares |
5-10-2023
Insider Buy |
Rosa Sugranes
Director |
$10.22
CAGR »
|
$19,904.66
1,948 shares |
5-4-2023
Insider Buy |
Wendy P. Davidson
Director |
$10.09
CAGR »
|
$100,897.50
10,000 shares |
5-4-2023
Insider Buy |
Colin V. Reed
Director |
$9.96
CAGR »
|
$250,404.65
25,138 shares |
4-29-2020
Insider Buy |
Wendy P. Davidson
Director |
$9.51
CAGR »
|
$28,515.00
3,000 shares |
4-29-2020
Insider Buy |
Mark A. Emkes
Director |
$9.42
CAGR »
|
$94,199.50
10,000 shares |
3-13-2020
Insider Buy |
Scott M. Niswonger
Director |
$9.40
CAGR »
|
$469,834.68
50,000 shares |
3-12-2020
Insider Buy |
Kenneth A. Burdick
Director |
$8.95
CAGR »
|
$44,750.00
5,000 shares |
3-12-2020
Insider Buy |
Scott M. Niswonger
Director |
$9.08
CAGR »
|
$907,700.00
100,000 shares |
12-10-2018
Insider Buy |
Scott M. Niswonger
Director |
$14.55
CAGR »
|
$363,763.00
25,000 shares |
10-31-2018
Insider Buy |
Yousef A. Valine
EVP & Chief Risk Officer |
$16.29
CAGR »
|
$48,870.00
3,000 shares |
10-19-2018
Insider Buy |
Scott M. Niswonger
Director |
$15.76
CAGR »
|
$788,243.50
50,000 shares |
8-1-2018
Insider Buy |
Scott M. Niswonger
Director |
$18.20
CAGR »
|
$1,820,000.00
100,000 shares |
7-25-2018
Insider Buy |
Mark A. Emkes
Director |
$17.68
CAGR »
|
$88,381.06
5,000 shares |
1-28-2016
Insider Buy |
John C. Compton
Director |
$12.63
CAGR »
|
$101,040.00
8,000 shares |
8-24-2012
Insider Buy |
Corydon J. Gilchrist
Director |
$8.48
CAGR »
|
$127,260.00
15,000 shares |
7-31-2012
Insider Buy |
Corydon J. Gilchrist
Director |
$8.20
CAGR »
|
$19,757.18
2,410 shares |
7-25-2012
Insider Buy |
John C. Compton
Director |
$8.01
CAGR »
|
$240,300.00
30,000 shares |
7-20-2011
Insider Buy |
Mark A. Emkes
Director |
$9.41
CAGR »
|
$18,816.36
2,000 shares |
Also See: Institutional Holders of FHN
Also See: SEC filings
Below we present the annualized performance delivered by FHN stock since 6-7-2023 (the date of the most recent
insider purchase). The performance of the investment from the time FHN insider buying occurred is the ultimate
test of whether insiders were right about FHN being a good buy.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
06/08/2023 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$11.71 |
|
| End price/share: |
$14.93 |
|
| Starting shares: |
853.97 |
|
| Ending shares: |
894.39 |
|
| Dividends reinvested/share: |
$0.60 |
|
| Total return: |
33.53% |
|
| Annualized Gain: |
38.13% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$13,353.00 |
|
| Years: |
0.88 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/08/2023 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$11.71 |
|
| End price/share: |
$14.93 |
|
| Dividends collected/share: |
$0.60 |
|
| Total return: |
32.62% |
|
| Annualized Gain: |
37.09% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$13,262.00 |
|
| Years: |
0.88 |
|
FHN Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent FHN insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding FHN
|
|
Free FHN Email Alerts:
